New electrical zapper targets inoperable liver tumors
NCT ID NCT07214363
Summary
This study is testing a new, FDA-approved electrical ablation technique for patients with liver cancer who cannot have surgery, specifically when tumors are dangerously close to major blood vessels. The procedure, called irreversible electroporation (IRE), uses high-voltage electrical pulses to destroy tumor cells while aiming to spare nearby blood vessels. Researchers will enroll 20 patients to see how well this method works and how safe it is over a four-month follow-up period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Taiwan University Hospital
Taipei, 100, Taiwan
Conditions
Explore the condition pages connected to this study.